Senator Sanders launches Senate investigation into ‘exorbitantly priced’ Ozempic and Wegovy drugs

Senator Bernie Sanders is investigating Novo Nordisk for high prices of Ozempic and Wegovy, injectable drugs for diabetes and weight loss. Sanders has written to the drugmaker questioning their pricing strategies and urging price reductions. Novo Nordisk has defended its prices, stating they are based on healthcare system changes and market conditions. The company remains committed to working with policymakers on access and affordability. The high prices of these drugs could strain federal healthcare programs like Medicare, with projected costs in the billions. This could lead to higher premiums for all beneficiaries.

Read more on amp.cnn.com